Hesslein Robert W. (CIK 0001585018)

Latest company ownership

VYGR - Voyager Therapeutics, Inc.

Role: Senior VP & General Counsel

Shares held

102,200

Last filed at

Mar 22, 2023

Confidence Score

50.0

2025Q4

Confidence Score History

2020Q2 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Mar 20, 2023	Mar 22, 2023	Voyager Therapeutics, Inc.	Senior VP & General Counsel	Sell	41.3	-4,410	-4.14%	✓	$34.2K
Feb 17, 2023	Feb 22, 2023	Voyager Therapeutics, Inc.	Senior VP & General Counsel	Sell	45.0	-3,297	-3.00%	✓	$24.6K
Feb 13, 2023	Feb 15, 2023	Voyager Therapeutics, Inc.	Senior VP & General Counsel	Sell	45.0	-2,868	-2.54%	✓	$22K
Jan 17, 2023	Jan 19, 2023	Voyager Therapeutics, Inc.	Senior VP & General Counsel	Sell	48.8	-2,188	-1.90%	✓	$21.5K
Apr 4, 2022	Apr 6, 2022	Voyager Therapeutics, Inc.	Senior VP & General Counsel	Sell	45.0	-2,786	-2.37%	✓	$23K
Mar 21, 2022	Mar 23, 2022	Voyager Therapeutics, Inc.	Senior VP & General Counsel	Sell	41.3	-4,955	-4.04%	✓	$41.1K
Feb 17, 2022	Feb 22, 2022	Voyager Therapeutics, Inc.	Senior VP & General Counsel	Sell	41.3	-4,100	-3.23%	✓	$14.6K
Feb 11, 2022	Feb 15, 2022	Voyager Therapeutics, Inc.	Senior VP & General Counsel	Sell	45.0	-3,252	-2.50%	✓	$10.9K
Apr 5, 2021	Apr 7, 2021	Voyager Therapeutics, Inc.	Senior VP & General Counsel	Buy	83.8	+3,292	3.08%	✓	$16.3K
Feb 11, 2021	Feb 16, 2021	Voyager Therapeutics, Inc.	Senior VP & General Counsel	Sell	36.3	-3,186	-6.06%	✓	$24.1K
Apr 3, 2020	Apr 7, 2020	Voyager Therapeutics, Inc.	Senior VP & General Counsel	Sell	36.3	-3,091	-5.56%	✓	$26.3K